We are delighted to announce that that we have another agreement signed with i2020 accelerator, following on from the one in 2019. This supports our group’s…
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test
A recent study from Finland reports that a protein kinase called LRRK2 is hyperactive in skin samples from Parkinson’s disease patients which leads to a decrease in protein synthesis.
University of Turku Signed a Significant Drug Development Licensing Agreement
The University of Turku has entered into a licensing agreement with an international pharma company related to targeting of CIP2A oncoprotein. …
Jane and Aatos Erkko Foundation Grants €1 million for Westermarck group
Jane and Aatos Erkko Foundation has awarded 975 000 € for research led by professor Jukka Westermarck and focused on phosphorylation mechanism under RAS oncoprotein.
New insights into regulation of human T-cells
Dissertation: Kartiek Kanduri, M.Sc. 5.6.2020, medical microbiology and immunology Kartiek Kanduri discovered several novel factors that regulate T-cell differentiation and function, Understanding the regulation of immune response is central for…
New funding for target discovery related to SynGAP1-associated non-syndromic intellectual disability
We are excited to be starting a new project on SynGAP thanks to support from Leon & friends e.V. SynGAP is a protein that reduces…
May’s funding news
Picture by Fusion Medical Animation on Unsplash. We are happy to announce the success of a number of research groups that received funding from the…
Report of the SAB visit
The Turku Bioscience and BioCity Turku common scientific advisory board visited the centre at the end of February. During their visit, they met reseach programme representatives and core facility personnel.
Webinar: NEUBIAS Academy Interactive Bioimage Analysis with Python and Jupyter
Advanced Learning, Demo, Q&As More information here …
US Department of Defense support breast cancer research at Turku Bioscience
Despite of continuous development of breast cancer treatments, metastases of the most aggressive breast cancer types are still a significant and growing medical problem. Together with a research group at…